Investigators report findings from one of the largest cohorts of patients treated with androgen receptor pathway inhibitors.
Latest observation follows reports of new autoimmune phenomena following COVID-19 vaccination, such as IgA nephropathy, rheumatoid arthritis, and systemic lupus erythematosus, investigators noted.
Investigators report 36-month data from the phase 2b ORIGIN trial.
The phase 3 EMBARK trial involved more than 200 global sites and had 8 years of follow-up.
Investigators report results from the phase 3 randomized EMBARK trial.
The cardioprotective effect was more pronounced with tadalafil than sildenafil.
Patients receiving peritoneal dialysis rather than hemodialysis or both modalities have the lowest rate of ESA hyporesponse.
Recent study provides insight into treatment outcomes over a relatively long time period.
Prophylaxis against Pneumocystis jirovecii pneumonia with trimethoprim-sulfamethoxazole reduced the risk for severe infections by nearly 77%, a study found.
Trend may reflect increasing use of systemic immunotherapies as first-line treatments, according to investigators.
